& Maratos-Flier, E
Semaglutide: A Game-Changer for PCOS Weight Loss Semaglutide belongs to a class of medications called GLP-1 receptor agonists, originally developed for type 2 diabetes but now showing impressive results for PCOS-related weight challenges
Peer review Peer review information Nature Medicine thanks Qiwei Li, Carel le Roux and Katherine Tuttle for their contribution to the peer review of this work
Only a healthcare provider can determine if a compounded medication is appropriate for your care
While individual results vary, most patients experience: Sustained progress in meeting their weight loss goals, especially with consistent use and healthy lifestyle habits Noticeable, often dramatic weight loss, especially after taking semaglutide for about 12 weeks when the optimal dose is reached Improved overall health, including better blood sugar levels and reduced risk of obesity-related diseases Semaglutide side effects As with any medical treatment, semaglutide may have some side effects
Judge Marston also oversees the Ozempic vision loss MDL in the Eastern District of Pennsylvania
&srotate=0)
